0001209191-19-031450.txt : 20190520
0001209191-19-031450.hdr.sgml : 20190520
20190520170820
ACCESSION NUMBER: 0001209191-19-031450
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190516
FILED AS OF DATE: 20190520
DATE AS OF CHANGE: 20190520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARCUS JOEL S
CENTRAL INDEX KEY: 0001216955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38898
FILM NUMBER: 19839696
MAIL ADDRESS:
STREET 1: C/O ALEXANDRIA REAL ESTATE EQUITIES, INC
STREET 2: 385 E. COLORADO BLVD. SUITE 299
CITY: PASADENA
STATE: CA
ZIP: 91101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Applied Therapeutics Inc.
CENTRAL INDEX KEY: 0001697532
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 340 MADISON AVENUE
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10173
BUSINESS PHONE: 212-220-9319
MAIL ADDRESS:
STREET 1: 340 MADISON AVENUE
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10173
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-16
0
0001697532
Applied Therapeutics Inc.
APLT
0001216955
MARCUS JOEL S
C/O APPLIED THERAPEUTICS, INC.
340 MADISON AVENUE, 19TH FLOOR
NEW YORK
NY
10173
1
0
0
0
Common Stock
2019-05-16
4
C
0
110497
A
119668
D
Common Stock
2019-05-16
4
C
0
135192
A
254860
D
Common Stock
2019-05-16
4
P
0
150000
10.00
A
404860
D
Series A Preferred Stock
2019-05-16
4
C
0
110497
0.00
D
Common Stock
110497
0
D
Series B Preferred Stock
2019-05-16
4
C
0
135192
0.00
D
Common Stock
135192
0
D
Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019.
/s/ Jason Minio, Attorney-in-Fact
2019-05-20